End points in clinical trials: are they moving the goalposts?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16775095.
- Also identified by PMC identifier 1860712.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In selecting and defining composite end points in clinical trials, are we trading off clinical significance for statistical significance?
Medical subject headings
- Clinical Trials as Topic
- Myocardial Infarction